Venture firm that in-licenses promising therapies and rapidly translates scientific discoveries into new medicines, focusing on the translational phase of drug development. Co-founded by former Novartis CEO Joe Jimenez and former Novartis Institutes for Biomedical Research President Mark Fishman.